PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Burleighs Gin is a company that aims to establish itself as the leader in the gin market. It is the official gin partner for entities such as Leicester City Football Club, Leicester Tigers RFC, and the King Richard III foundation. Burleighs plans to introduce a 'non-alcoholic gin' apart from its gin products. The company feels that this will allow Burleighs to enter into the rapidly rising 'low & no' growth sector, now valued at £60 million a year in the UK. It also intends to commission the production of a 'Ready to Drink Gin & Tonic' in a can, another growth market driven by the popularity of gin that is now worth £472 million a year. Burleighs has on-trade listings secured with Cosy Club, Loungers, All Bar One, and Miller & Carter. It has hosted consumer events during 2019 including; Picnic in the Gardens, World Gin Day festival and The Great Burleighs Express. Burleighs Gin has been featured in BBC Good Food Guide's 'Best Gins to try in 2019'. They will use 50% of the investment for new product development, 15% for distillery expansion, 15% for recruitment drives, 10% for export growth, and 10% as marketing expenses.
days to go:
Expired
investment:
£130,490
Staks is a one-stop-shop for supplements. Their pouches contain a whole days combination of supplements in single serving sachets. Staks is ideal for people that are unsure on what supplements to take or simply don't have time to organise a supplement plan.
days to go:
Expired
investment:
£10,460
WELD is a fitness company on a mission to make on-demand health, fitness and wellbeing available to all ages & abilities. The company allows users and instructors to set the time and place for the training session, rent out their home or commercial spaces for activities, or interact 1-2-1 online. This approach, the company believes, helps personal trainers, hit by the Covid-19 lockdown, find clients. WELD also allows trainers to set their prices and keep 90% of their fees, and lets customers enjoy a 2% commission on referrals for every future session taken in perpetuity. WELD aims to tap into the $94 billion global fitness and wellness market that grew 8.7% from 2018/19. The company's primary target audience is Generation Z that, the company believes, embraced wellness. WELD will use the investment to improve its platform, boost marketing and plug the fitness & wellness gap.
days to go:
Expired
investment:
£199,227
Guest are creating the world's best cocktail bar. They aim to do this by offering a new menu from some of the most creative food and cocktail innovators in the world. With the money invested Guest are going to place a deposit on a venue for the bar, refurbish and fit out the venue and then start an international marketing campaign.
days to go:
Expired
investment:
£107,180
Canny make and sell all natural flavoured milkshakes which are already being listed in stores across the UK and on Virgin trains. The 100% natural drinks provide 11 grams of protein per bottle and have less than 5% sugar, and will be launching a no refined sugar option this summer.
days to go:
Expired
investment:
£172,780
